Cholesterol metabolism in the brain.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic and physiological literature without systematic methodology
PubMed 11264981 · doi:10.1097/00041433-200104000-00003
What was done
This narrative review summarizes physiological and biochemical evidence on cholesterol pools, in situ synthesis, turnover rates, recycling mechanisms, and elimination pathways within the mammalian central nervous system, including alterations in neurodegenerative conditions.
What was found
The central nervous system comprises approximately 2% of whole body mass but contains nearly 25% of unesterified whole-body cholesterol, localized to glial/neuronal membranes and myelin. Daily turnover rates range from 0.02% in humans to 0.4% in mice, resulting in sterol flux across the brain that is only about 0.9% as rapid as whole-body turnover. Brain cholesterol originates almost entirely from local in situ synthesis, with negligible net sterol transfer from plasma across fetal, newborn, or adult stages. Steady-state output is partly mediated by 24S-hydroxycholesterol formation and excretion. Cholesterol turnover increases in neurodegenerative disorders such as Alzheimer disease and Niemann-Pick type C disease, with internal recycling involving apolipoproteins E and AI and low-density lipoprotein receptor family members.
Why it matters
The paper outlines the autonomous regulation of brain cholesterol metabolism separate from peripheral circulation, providing a physiological basis for understanding lipid dysregulation in neurodegenerative diseases.
Limits
As a narrative review, it lacks systematic search criteria, individual study sample sizes, effect size metrics, or direct primary data. Observations rely partly on indirect evidence and animal models.
Cited by
- supports 25% of the total cholesterol in the human body is located in the brain.